These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 37124926)
1. Neurodevelopmental disorders, like cancer, are connected to impaired chromatin remodelers, PI3K/mTOR, and PAK1-regulated MAPK. Nussinov R; Yavuz BR; Arici MK; Demirel HC; Zhang M; Liu Y; Tsai CJ; Jang H; Tuncbag N Biophys Rev; 2023 Apr; 15(2):163-181. PubMed ID: 37124926 [TBL] [Abstract][Full Text] [Related]
2. The emerging role of chromatin remodelers in neurodevelopmental disorders: a developmental perspective. Mossink B; Negwer M; Schubert D; Nadif Kasri N Cell Mol Life Sci; 2021 Mar; 78(6):2517-2563. PubMed ID: 33263776 [TBL] [Abstract][Full Text] [Related]
3. SHP2 clinical phenotype, cancer, or RASopathies, can be predicted by mutant conformational propensities. Liu Y; Zhang W; Jang H; Nussinov R Cell Mol Life Sci; 2023 Dec; 81(1):5. PubMed ID: 38085330 [TBL] [Abstract][Full Text] [Related]
4. Dysregulation of Neurite Outgrowth and Cell Migration in Autism and Other Neurodevelopmental Disorders. Prem S; Millonig JH; DiCicco-Bloom E Adv Neurobiol; 2020; 25():109-153. PubMed ID: 32578146 [TBL] [Abstract][Full Text] [Related]
5. Neurodevelopmental disorders and cancer networks share pathways, but differ in mechanisms, signaling strength, and outcome. Yavuz BR; Arici MK; Demirel HC; Tsai CJ; Jang H; Nussinov R; Tuncbag N NPJ Genom Med; 2023 Nov; 8(1):37. PubMed ID: 37925498 [TBL] [Abstract][Full Text] [Related]
6. Reprogramming of the epigenome in neurodevelopmental disorders. Wilson KD; Porter EG; Garcia BA Crit Rev Biochem Mol Biol; 2022 Feb; 57(1):73-112. PubMed ID: 34601997 [TBL] [Abstract][Full Text] [Related]
7. Neurodevelopmental disorders, immunity, and cancer are connected. Nussinov R; Tsai CJ; Jang H iScience; 2022 Jun; 25(6):104492. PubMed ID: 35712080 [TBL] [Abstract][Full Text] [Related]
8. Unraveling the three-dimensional (3D) genome architecture in Neurodevelopmental Disorders (NDDs). Carballo-Pacoret P; Carracedo A; Rodriguez-Fontenla C Neurogenetics; 2024 Oct; 25(4):293-305. PubMed ID: 39190242 [TBL] [Abstract][Full Text] [Related]
9. Zmiz1 is a novel regulator of brain development associated with autism and intellectual disability. K C R; Tiemroth AS; Thurmon AN; Meadows SM; Galazo MJ Front Psychiatry; 2024; 15():1375492. PubMed ID: 38686122 [TBL] [Abstract][Full Text] [Related]
10. Neurodevelopmental Disorders: From Genetics to Functional Pathways. Parenti I; Rabaneda LG; Schoen H; Novarino G Trends Neurosci; 2020 Aug; 43(8):608-621. PubMed ID: 32507511 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive immunoprofiling of neurodevelopmental disorders suggests three distinct classes based on increased neurogenesis, Th-1 polarization or IL-1 signaling. Sreenivas N; Maes M; Padmanabha H; Dharmendra A; Chakkera P; Paul Choudhury S; Abdul F; Mullapudi T; Gowda VK; Berk M; Vijay Sagar Kommu J; Debnath M Brain Behav Immun; 2024 Jan; 115():505-516. PubMed ID: 37972879 [TBL] [Abstract][Full Text] [Related]
12. Identification of a transcriptional signature found in multiple models of ASD and related disorders. Thudium S; Palozola K; L'Her É; Korb E Genome Res; 2022 Sep; 32(9):1642-1654. PubMed ID: 36104286 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation of Lewerissa EI; Nadif Kasri N; Linda K Autophagy; 2024 Jan; 20(1):15-28. PubMed ID: 37674294 [TBL] [Abstract][Full Text] [Related]
14. Integrated Bayesian analysis of rare exonic variants to identify risk genes for schizophrenia and neurodevelopmental disorders. Nguyen HT; Bryois J; Kim A; Dobbyn A; Huckins LM; Munoz-Manchado AB; Ruderfer DM; Genovese G; Fromer M; Xu X; Pinto D; Linnarsson S; Verhage M; Smit AB; Hjerling-Leffler J; Buxbaum JD; Hultman C; Sklar P; Purcell SM; Lage K; He X; Sullivan PF; Stahl EA Genome Med; 2017 Dec; 9(1):114. PubMed ID: 29262854 [TBL] [Abstract][Full Text] [Related]
15. Rare deleterious mutations of HNRNP genes result in shared neurodevelopmental disorders. Gillentine MA; Wang T; Hoekzema K; Rosenfeld J; Liu P; Guo H; Kim CN; De Vries BBA; Vissers LELM; Nordenskjold M; Kvarnung M; Lindstrand A; Nordgren A; Gecz J; Iascone M; Cereda A; Scatigno A; Maitz S; Zanni G; Bertini E; Zweier C; Schuhmann S; Wiesener A; Pepper M; Panjwani H; Torti E; Abid F; Anselm I; Srivastava S; Atwal P; Bacino CA; Bhat G; Cobian K; Bird LM; Friedman J; Wright MS; Callewaert B; Petit F; Mathieu S; Afenjar A; Christensen CK; White KM; Elpeleg O; Berger I; Espineli EJ; Fagerberg C; Brasch-Andersen C; Hansen LK; Feyma T; Hughes S; Thiffault I; Sullivan B; Yan S; Keller K; Keren B; Mignot C; Kooy F; Meuwissen M; Basinger A; Kukolich M; Philips M; Ortega L; Drummond-Borg M; Lauridsen M; Sorensen K; Lehman A; ; Lopez-Rangel E; Levy P; Lessel D; Lotze T; Madan-Khetarpal S; Sebastian J; Vento J; Vats D; Benman LM; Mckee S; Mirzaa GM; Muss C; Pappas J; Peeters H; Romano C; Elia M; Galesi O; Simon MEH; van Gassen KLI; Simpson K; Stratton R; Syed S; Thevenon J; Palafoll IV; Vitobello A; Bournez M; Faivre L; Xia K; ; Earl RK; Nowakowski T; Bernier RA; Eichler EE Genome Med; 2021 Apr; 13(1):63. PubMed ID: 33874999 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of PAK1 promotes cell survival in inflammatory bowel diseases and colitis-associated cancer. Khare V; Dammann K; Asboth M; Krnjic A; Jambrich M; Gasche C Inflamm Bowel Dis; 2015 Feb; 21(2):287-96. PubMed ID: 25569743 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of Seizures in Children Diagnosed With Neurodevelopmental Disorders. Muthaffar OY; Abbar AY; Fitaih MT Cureus; 2024 Jul; 16(7):e63765. PubMed ID: 39099967 [TBL] [Abstract][Full Text] [Related]
18. Pathogenic Song JM; Kang M; Park DH; Park S; Lee S; Suh YH J Neurosci; 2021 Mar; 41(11):2344-2359. PubMed ID: 33500274 [TBL] [Abstract][Full Text] [Related]